Eudesmanolide from Salvia plebeia Protects H9c2 Cardiomyocytes Against Hypoxia/Reoxygenation-Induced Apoptosis with Nrf2 Activation

Xue-Lian Jin,Song Wang
2022-01-01
Latin american journal of pharmacy
Abstract:Myocardial infarction is one of the leading causes of mortality and disability all over the world. To find novel therapy for myocardial infarction, we have identified eudesmanolide from Salvia plebeia and evaluated its protective effects using H9c2 cardiomyocytes induced by hypoxia/reoxygenation. The results showed eudesmanolide improved the cell survival via increasing cell viability and blocking the release of LDH. Further explorations revealed eudesmanolide attenuated mitochondrial dysfunction, oxidative stress and apoptosis resulting from hypoxia/reoxygenation in H9c2 cardiomyocytes. In addition, it was observed eudesmanolide activated Nrf2 in H9c2 cardiomyocytes, which is closely associated with its protective effects. Taken together, these findings give evidences for the discovery of drugs targeting myocardial infarction and the application of eudesmanolide in clinical practice.
What problem does this paper attempt to address?